JNJ takeover

JNJ take over rumor? Any thoughts?

 

No way. Word on street is Biogen/Amgen merger

 

we would destroy them. They have a really cool culture. Out culture sucks! Biogen is what amgen was 10 years ago.

I hope for the employees of Biogen that we don't buy them.

 

They would make us better!

 

Our culture sux due directly to the influence of Bradway,Hooper & Hoffman….period!

 

Bring it on. Release us from these shackles.

 

Only thing that would make Amgen better is a nuclear strike. Amgen and TO is where Lucifer sends his worst demons!

 

This dog needs to be put to sleep. J&J is the vet ready to do the job. Bye Bye Banker Boyz!

 

This is exactly what BB does best, and you can bet the deal will be sweetest for him.

 

JnJ Share buybacks makes people speculate some M&A. They are going to take over Amgen ppl! Rejoice!

 

Speculation but why Amgen. There are other companies.

 

Amgen has second rate talent and why sales are not as strong as they could be. JnJ would maximize the products Amgen has.

Johnson & Johnson executives, embarking on a $10 billion share buyback program, emphasized Tuesday they still have the cash and the appetite for deals.

"I wouldn’t interpret the $10 billion share buyback as impacting our appetite for scale of any size in M&A at all," Chief Financial Officer Dominic Caruso said on a conference call Tuesday. "Our appetite for M&A of any scale has entirely to do with whether or not the acquisition is going to create value for shareholders."

His language leaves the door open for large-scale deals in an industry where transactions in the tens of billions of dollars aren’t uncommon. Nine acquisitions of $10 billion or more have been proposed, agreed to or completed thus far this year in the drug industry, according to data compiled by Bloomberg.


J&J’s repurchase program has no time limit, and the company had $37 billion in cash, equivalents and short-term investments at the end of the third quarter, leaving plenty of room for acquisitions. Management is "very disciplined" about what kinds of deals it pursues, Caruso said.

"They’re saying, ‘We need to do something here because we have this buildup of cash and we need to deploy it in some fashion because we don’t have a ready asset we can go out and buy,’" said Tony Butler, an analyst at Guggenheim Securities.

Caruso said the pharmaceutical division is focused on five key therapeutic areas: oncology, immunology, neuroscience, cardiovascular, and infectious disease and vaccines.

J&J has two other lines of business -- consumer products and medical devices -- and it has the capability to pursue a deal in any of the three.


The planned repurchases, double the amount allocated last year, may be an acknowledgment that the company doesn’t have any large-scale targets in its sights right now. After losing out to AbbVie Inc. in March in the bidding for cancer drug maker Pharmacyclics Inc., which ended up selling for $21 billion, the health-care giant hasn’t made another reported attempt to participate in the consolidation of the pharmaceutical industry’s biggest companies.

 

Amgen product patents are expiring and have to deal with biosimilar competition. If acquired, jnj would also have to deal with it.smaller companies have platforms or technologies that Amgen might not help. They can focus on oncology or cardiovascular but cardiovascular is quite new at Amgen. They did leave the statement for interpretation and speculation. The repurchase program has no set date so it could be months or years.

 

www.bloomberg.com/.../allergan-may-turn-sights-to-am.

 

Gone silent.

Lot of "suits" in TO -- Due Diligence taking place?

Hope JNJ realizes that this company needs more than a Band-Aid!

 

Bradway in New Brunswick, NJ on Friday. Hassan also in tow. Those in the know say the acquisition deal will be announced late next week. It was reported that the terms will result in the integration of the Amgen sales force into Janssen. Sales and Marketing will be moved to Janssen HQ in Titusville. R&D will be absorbed into other Janssen facilities in New Jersey and Pennsylvania.

Stay tuned, more to follow

 

What will happen to staffs in TO? Moving to New Jersey or Philly? Will AFP project be stalled?

 

Thanks for the info. Earning call is next week. The news is going to follow that?

 

Bradway in NJ this last Friday or will he be there next Friday?

 

Don't believe it. It's all a lie by an FDA boy